PMID- 28985587 OWN - NLM STAT- MEDLINE DCOM- 20180504 LR - 20181202 IS - 1573-2517 (Electronic) IS - 0165-0327 (Linking) VI - 226 DP - 2018 Jan 15 TI - Cerebrospinal fluid D-serine concentrations in major depressive disorder negatively correlate with depression severity. PG - 155-162 LID - S0165-0327(17)30775-9 [pii] LID - 10.1016/j.jad.2017.09.035 [doi] AB - BACKGROUND: D-serine is an endogenous co-agonist of N-methyl-D-aspartate receptor (NMDAR) and plays an important role in glutamate neurotransmission. Several studies suggested the possible involvement of D-serine related in the pathophysiology of psychiatric disorders including major depression disorders (MDD). We tried to examine whether cerebrospinal fluid (CSF) or plasma D-serine concentrations are altered in MDD and whether D-serine concentrations correlated with disease severity. METHODS: 26 MDD patients and 27 healthy controls matched for age, sex and ethnicity were enrolled. We measured amino acids in these samples using by high-performance liquid chromatography with fluorometric detection. RESULTS: D-serine and L-serine, precursor of D-serine, levels in CSF or plasma were not significantly different in patients of MDD compared to controls. Furthermore, a significant correlation between D-serine levels in CSF and Hamilton Depression Rating Scale (HAMD)-17 score was observed (r = -0.65, p = 0.006). Furthermore, we found a positive correlation between CSF D-serine and HVA concentrations in MDD patients (r = 0.54, p = 0.007). CSF D-serine concentrations were correlated with those of plasma in MDD (r = 0.61, p = 0.01) but not in controls. In CSF, we also confirmed a significant correlation between D-serine and L-serine levels in MDD (r = 0.72, p < 0.0001) and controls (r = 0.70, p < 0.0001). CONCLUSIONS: The study has some limitations; sample size was relatively small and most patients were medicated. We revealed that CSF D-serine concentrations were correlated with depression severity and HVA concentrations and further investigation were required to reveal the effect of medication and disease heterogeneity. CI - Copyright (c) 2017 Elsevier B.V. All rights reserved. FAU - Ishiwata, Sayuri AU - Ishiwata S AD - Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan; Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8519, Japan. FAU - Hattori, Kotaro AU - Hattori K AD - Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan; Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan. FAU - Sasayama, Daimei AU - Sasayama D AD - Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan. FAU - Teraishi, Toshiya AU - Teraishi T AD - Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan. FAU - Miyakawa, Tomoko AU - Miyakawa T AD - Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan. FAU - Yokota, Yuuki AU - Yokota Y AD - Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan. FAU - Matsumura, Ryo AU - Matsumura R AD - Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan. FAU - Nishikawa, Toru AU - Nishikawa T AD - Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8519, Japan. FAU - Kunugi, Hiroshi AU - Kunugi H AD - Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan. Electronic address: hkunugi@ncnp.go.jp. LA - eng PT - Journal Article DEP - 20170927 PL - Netherlands TA - J Affect Disord JT - Journal of affective disorders JID - 7906073 RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 452VLY9402 (Serine) SB - IM MH - Adult MH - Chromatography, High Pressure Liquid MH - Depression/physiopathology MH - Depressive Disorder, Major/*cerebrospinal fluid/physiopathology MH - Female MH - Humans MH - Male MH - Middle Aged MH - Psychiatric Status Rating Scales MH - Receptors, N-Methyl-D-Aspartate MH - Serine/*cerebrospinal fluid MH - Young Adult OTO - NOTNLM OT - D-serine OT - Depression OT - HVA OT - L-serine EDAT- 2017/10/07 06:00 MHDA- 2018/05/05 06:00 CRDT- 2017/10/07 06:00 PHST- 2017/04/15 00:00 [received] PHST- 2017/07/09 00:00 [revised] PHST- 2017/09/23 00:00 [accepted] PHST- 2017/10/07 06:00 [pubmed] PHST- 2018/05/05 06:00 [medline] PHST- 2017/10/07 06:00 [entrez] AID - S0165-0327(17)30775-9 [pii] AID - 10.1016/j.jad.2017.09.035 [doi] PST - ppublish SO - J Affect Disord. 2018 Jan 15;226:155-162. doi: 10.1016/j.jad.2017.09.035. Epub 2017 Sep 27.